摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (1'-amino)ferrocenecarboxylic acid | 206275-03-8

中文名称
——
中文别名
——
英文名称
methyl (1'-amino)ferrocenecarboxylic acid
英文别名
methyl 1'-aminoferrocene-1-carboxylate;1-amino-n'-ferrocenemethylcarboxylate;1-amino-1'-ferrocene carboxylic acid methyl ester;cyclopenta-2,4-dien-1-amine;iron(2+);methyl cyclopenta-1,3-diene-1-carboxylate
methyl (1'-amino)ferrocenecarboxylic acid化学式
CAS
206275-03-8
化学式
C12H13FeNO2
mdl
——
分子量
259.088
InChiKey
MDWFQRKUYFQHRG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.18
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    52.3
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    methyl (1'-amino)ferrocenecarboxylic acid 、 9-fluorenylmethyloxocarbonyl-1-amino-1'-ferrocene carboxylic acid 在 1-chloro-N,N-2-trimethyl-1-propenylamine 、 Zn 作用下, 以 二氯甲烷 为溶剂, 以79%的产率得到
    参考文献:
    名称:
    二茂铁氨基酸对氧化还原反应的有机金属折叠剂:固相合成,二级结构和混合价性质†
    摘要:
    寡二茂铁 Fmoc - Fca n - OMe(n = 3–5)以逐步精确的方式从Fmoc受保护 二茂铁氨基酸Fmoc - Fca - OH(^ h - FCA - OH = 1-氨基-1'-二茂铁羧酸; Fmoc = 9-芴基甲氧基羰基)依次通过固体支持物上的酰胺键Fmoc脱保护,酸活化和偶联步骤。生成的定义明确的低聚物在其中形成有序的锯齿形结构四氢呋喃 具有特征的解决方案 氢粘接模式。电化学实验揭示了个体的顺序氧化二茂铁这些肽中的单位会产生混合价阳离子。光学间隔电子转移是通过近红外中的间隔跃迁来检测的。
    DOI:
    10.1039/c0dt01528h
  • 作为产物:
    参考文献:
    名称:
    多响应二茂铁-苯酚共轭物的构象转换
    摘要:
    基于二茂铁基-水杨酸酰胺基序的多功能构象开关在 Fc 部分(R = COOMe、CONHEt、CONHFc;H-2-H-4;Fc = 二茂铁基)增加了额外的复杂性,并且它们优选的二级结构在已通过核磁共振和红外光谱结合基于 DFT 计算的构象搜索阐明了解决方案。它们对去质子化 ([2]––[4]–) 和氧化 ([H-2]+·–[H-4]+·) 的独特构象响应已通过红外、EPR 和紫外/可见光谱揭示为以及通过 DFT 计算。去质子化反转所有酰胺单元(双酰胺扭曲),而氧化选择性地翻转末端酰胺单元(单酰胺扭曲)。还探索了去质子化和氧化的联合作用。
    DOI:
    10.1002/ejoc.201600774
点击查看最新优质反应信息

文献信息

  • The synthesis and characterisation of heterosubstituted aminoferrocenes
    作者:Ian R Butler、Scott C Quayle
    DOI:10.1016/s0022-328x(97)00528-7
    日期:1998.2
    The synthesis of 1-bromo-1′-aminoferrocene is reported using a simple synthetic methodology. This compound serves as a useful precursor to other heterosubstituted aminoferrocenes. For example, (1′-amino)ferrocenecarboxylic acid has been obtained and is conveniently isolated in its C-protected form by lithiation of 1-bromo-1′-aminoferrocene, quenching with solid carbon dioxide and esterification of
    使用简单的合成方法报道了1--1'-氨基二茂铁的合成。该化合物用作其他杂取代的氨基二茂铁的有用前体。例如,已经获得了(1'-基)二茂铁羧酸,并且通过1--1'-氨基二茂铁化,用固体二氧化碳淬灭并用甲醇的HCl将所得的羧酸酯化而方便地以其C-保护的形式分离出(1'-基)二茂铁羧酸。 。还使用类似的方法获得了新的配体1-二苯基膦基-1'-氨基二茂铁
  • Ferrocene tripeptide Gly-Pro-Arg conjugates: Synthesis and inhibitory effects on Alzheimer’s Aβ1–42 fibrillogenesis and Aβ-induced cytotoxicity in vitro
    作者:Binbin Zhou、Chun-Lan Li、Yuan-Qiang Hao、Muya Chabu Johnny、You-Nian Liu、Juan Li
    DOI:10.1016/j.bmc.2012.11.030
    日期:2013.1
    Alzheimer's disease (AD) is the most common cause of dementia, and currently there is no clinical treatment to cure it or to halt its progression. Aggregation and fibril formation of beta-amyloid peptides (A beta) are central events in the pathogenesis of AD. Many efforts have been spent on the development of effective inhibitors to prevent A beta fibrillogenesis and cause disaggregation of preformed A beta fibrils. In this study, the conjugates of ferrocene and Gly-Pro-Arg (GPR) tripeptide, Boc-Gly-Pro-Arg(NO2)-Fca-OMe (4, GPR-Fca) and Fc-Gly-Pro-Arg-OMe (7, Fc-GPR) (Fc: ferrocene; Fca: ferrocene amino acid) were synthesized by HOBT/HBTU protocol in solution. These ferrocene GPR conjugates were employed to inhibit A beta(1-42) fibrillogenesis and to disaggregate preformed A beta fibrils. The inhibitory properties of ferrocene GPR conjugates on A beta(1-42) fibrillogenesis were evaluated by thioflavin T (ThT) fluorescence assay, and confirmed by atomic force microscopy (AFM) analysis. The interaction between the ferrocene GPR conjugates and A beta(1-42) was monitored by electrochemical means. Our results showed that both GPR and GPR-Fca can significantly inhibit the fibril formation of A beta(1-42), and cause disaggregation of the preformed fibrils. As expected, GPR-Fca shows stronger inhibitory effect on A beta(1-42) fibrillogenesis than that of its parent peptide GPR. In contrast, Fc-GPR shows no inhibitory effect on fibrillogenesis of A beta(1-42). Furthermore, GPR-Fca demonstrates significantly protection against A beta-induced cytotoxicity and exhibits high resistance to proteolysis and good lipophilicity. (C) 2012 Elsevier Ltd. All rights reserved.
  • Ferrocene compounds: methyl 1′-aminoferrocene-1-carboxylate
    作者:Christoph Förster、Daniel Siebler、Katja Heinze
    DOI:10.1107/s0108270110025746
    日期:2010.9.15
    The title compund, [Fe(C(5)H(6)N)(C(7)H(7)O(2))], features one strong intermolecular hydrogen bond of the type N-H...O=C [N...O = 3.028 (2) A] between the amine group and the carbonyl group of a neighbouring molecule, and vice versa, to form a centrosymmetric dimer. Furthermore, the carbonyl group acts as a double H-atom acceptor in the formation of a second, weaker, hydrogen bond of the type C-H...O=C [C...O = 3.283 (2) A] with the methyl group of the ester group of a second neighbouring molecule at (x, -y - 1/2, z - 1/2). The methyl group also acts as a weak hydrogen-bond donor, symmetry-related to the latter described C-H...O=C interaction, to a third molecule at (x, -y - 1/2, z + 1/2) to form a two-dimensional network. The cyclopentadienyl rings of the ferrocene unit are parallel to each other within 0.33 (3) degrees and show an almost eclipsed 1,1'-conformation, with a relative twist angle of 9.32 (12) degrees . The ester group is twisted slightly [11.33 (8) degrees ] relative to the cylopentadienyl plane due to the above-mentioned intermolecular hydrogen bonds of the carbonyl group. The N atom shows pyramidal coordination geometry, with the sum of the X-N-Y angles being 340 (3) degrees .
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸